Innovex International, Inc. (INVX) president sells 10,000 shares under 10b5-1 plan

Rhea-AI Filing Summary

Innovex International, Inc. executive Mark Reddout, President of North America, reported selling 10,000 shares of Common Stock on August 4, 2026 at $30.00 per share. The sale is described as an open market or private transaction under a Rule 10b5-1 plan adopted on March 2, 2026. Following this trade, he directly holds 124,312 shares.

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares

Net Sell 1 txn

Insider Reddout Mark

Role President of North America

Sold 10,000 shs ($300K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	10,000	$30.00	$300K

Holdings After Transaction: Common Stock — 124,312 shares (Direct)

Footnotes (2)

1. F1. Sales pursuant to a Rule 10b5-1 plan adopted on March 2, 2026.
2. F2. All shares were sold at the price in column 4.

Key Figures

Shares sold: 10,000 shares Sale price per share: $30.0000 per share Shares held after sale: 124,312 shares +1 more

4 metrics

Shares sold 10,000 shares Common Stock sale reported for August 4, 2026

Sale price per share $30.0000 per share Price applied to all shares in the reported transaction

Shares held after sale 124,312 shares Direct Common Stock holdings following the transaction

Rule 10b5-1 plan adoption date March 2, 2026 Adoption date of the trading plan governing the reported sale

Key Terms

Rule 10b5-1 plan, open market or private transaction, Common Stock

3 terms

Rule 10b5-1 plan regulatory

"Sales pursuant to a Rule 10b5-1 plan adopted on March 2, 2026."

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

open market or private transaction financial

"Transaction code description: Sale in open market or private transaction."

Common Stock financial

"Security title for the transaction is Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/05/2026 - 06:00 PM Accepted by SEC EDGAR 08/05/2026 - 06:00 PM Learn about SEC filing dates

FAQ

What insider transaction did Innovex International, Inc. (INVX) disclose for Mark Reddout?

Mark Reddout sold 10,000 shares of Innovex International, Inc. Common Stock. The sale occurred on August 4, 2026 at $30.00 per share and was reported as an open market or private transaction.

At what price were the INVX shares sold in Mark Reddout’s recent Form 4 filing?

All reported Innovex (INVX) shares were sold at $30.00 per share. A footnote specifies that every share in the 10,000-share transaction was executed at this same price, as shown in column 4 of the Form 4 table.

How many Innovex International, Inc. (INVX) shares does Mark Reddout hold after this sale?

After the sale, Mark Reddout directly holds 124,312 shares of Innovex International, Inc. Common Stock. This post-transaction balance is reported in the Form 4 as his direct ownership following the 10,000-share disposition.

Was Mark Reddout’s INVX stock sale made under a Rule 10b5-1 plan?

Yes. The Form 4 notes that the 10,000-share sale was executed pursuant to a Rule 10b5-1 plan. A footnote states the plan was adopted on March 2, 2026, and the filing’s 10b5-1 checkbox is marked true.

What is Mark Reddout’s role at Innovex International, Inc. (INVX) related to this Form 4?

Mark Reddout is identified as President of North America at Innovex International, Inc. He is an officer but not listed as a director or 10% owner, and the Form 4 reports his 10,000-share sale and resulting holdings of 124,312 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reddout Mark

(Last) (First) (Middle)

C/O INNOVEX INTERNATIONAL, INC.

19120 KENSWICK DRIVE

(Street)

HUMBLE TEXAS 77338

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President of North America

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2026		S		10,000(1)	D	$30(2)	124,312	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales pursuant to a Rule 10b5-1 plan adopted on March 2, 2026.

2. All shares were sold at the price in column 4.

	/s/ Matt Steinheider, Attorney-in-Fact for Mark Reddout	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)